What is Xenon Pharmaceuticals Price-to-Free-Cash-Flow?
As of today (2024-05-16), Xenon Pharmaceuticals's share price is €37.40.
Xenon Pharmaceuticals's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.09. Hence, Xenon Pharmaceuticals's Price-to-Free-Cash-Flow Ratio for today is N/A.
The historical rank and industry rank for Xenon Pharmaceuticals's Price-to-Free-Cash-Flow or its related term are showing as below:
During the past 13 years, Xenon Pharmaceuticals's highest Price-to-Free-Cash-Flow Ratio was 210.49. The lowest was 156.17. And the median was 168.21.
FRA:XP0's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 32.39 * Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -15.40% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was -22.70% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was -14.50% per year.
During the past 13 years, Xenon Pharmaceuticals's highest 3-Year average Free Cash Flow per Share Growth Rate was 43.60% per year. The lowest was -93.80% per year. And the median was -11.60% per year.
Xenon Pharmaceuticals Price-to-Free-Cash-Flow Historical Data
The historical data trend for Xenon Pharmaceuticals's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Xenon Pharmaceuticals's Price-to-Free-Cash-Flow
For the Biotechnology subindustry, Xenon Pharmaceuticals's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xenon Pharmaceuticals's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Xenon Pharmaceuticals's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Xenon Pharmaceuticals's Price-to-Free-Cash-Flow falls into.
Xenon Pharmaceuticals's Share Price of today is €37.40. Xenon Pharmaceuticals's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.09.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Xenon Pharmaceuticals Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Xenon Pharmaceuticals's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Xenon Pharmaceuticals (FRA:XP0) Business Description
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:XP0 has been successfully added to your 